Literature DB >> 8879131

Molecular cloning and sequence determination of the complete genome of the virulent echovirus 9 strain barty.

H Zimmermann1, H J Eggers, B Nelsen-Salz.   

Abstract

As part of a study of the molecular basis of pathogenicity of echovirus 9, the complete nucleotide sequence of the mouse-virulent echovirus 9 strain Barty was determined. Excluding the poly(A) tail, the complete RNA genome is composed of 7451 bases. The postulated open reading frame extends from nucleotide (nt) 741 to 7349 and predicts a polyprotein of 2203 amino acids (aa). As compared with the sequence of the echovirus 9 prototype strain Hill, which is apathogenic for newborn mice, 1492 nt are exchanged, leading to 9% divergence of the deduced amino acid sequence. The foremost difference between both strains is located at the C-terminus of the capsid protein VP1. In the case of strain Barty, an additional 10 aa fragment, including an RGD motif, is inserted.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879131     DOI: 10.1007/bf00572953

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  12 in total

1.  ENTERIC cytopathogenic human orphan (ECHO) viruses.

Authors: 
Journal:  Science       Date:  1955-12-16       Impact factor: 47.728

2.  Infectious cDNA clones of echovirus 12 and a variant resistant against the uncoating inhibitor rhodanine differ in seven amino acids.

Authors:  W Kraus; H Zimmermann; A Zimmermann; H J Eggers; B Nelsen-Salz
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

3.  Cleavage sites within the poliovirus capsid protein precursors.

Authors:  G R Larsen; C W Anderson; A J Dorner; B L Semler; E Wimmer
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

4.  The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classification.

Authors:  K H Chang; P Auvinen; T Hyypiä; G Stanway
Journal:  J Gen Virol       Date:  1989-12       Impact factor: 3.891

5.  Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group.

Authors:  G Stanway; N Kalkkinen; M Roivainen; F Ghazi; M Khan; M Smyth; O Meurman; T Hyypiä
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  HPLC is an effective and fast method for analysis of viral proteins: a study of encephalomyocarditis virus mutants differing in pathogenicity.

Authors:  A Zimmermann; T Mertens; A Schulz; J P Kruppenbacher; B Nelsen-Salz; H J Eggers
Journal:  J Gen Virol       Date:  1993-12       Impact factor: 3.891

7.  Four-year study of WHO virus reports on enteroviruses other than poliovirus.

Authors:  F Assaad; W C Cockburn
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

8.  RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway.

Authors:  P W Mason; E Rieder; B Baxt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

9.  RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases.

Authors:  M Roivainen; T Hyypiä; L Piirainen; N Kalkkinen; G Stanway; T Hovi
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

10.  Factors determining pathogenicity of variants of ECHO 9 virus for newborn mice.

Authors:  H J EGGERS; A B SABIN
Journal:  J Exp Med       Date:  1959-12-01       Impact factor: 14.307

View more
  11 in total

1.  Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry.

Authors:  Y Boonyakiat; P J Hughes; F Ghazi; G Stanway
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification.

Authors:  M S Oberste; K Maher; D R Kilpatrick; M A Pallansch
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

3.  Entry of human parechovirus 1.

Authors:  P Joki-Korpela; V Marjomäki; C Krogerus; J Heino; T Hyypiä
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Dependence of echovirus 9 on the enterovirus RNA replication inhibitor 2-(alpha-Hydroxybenzyl)-benzimidazole maps to nonstructural protein 2C.

Authors:  D Hadaschik; M Klein; H Zimmermann; H J Eggers; B Nelsen-Salz
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.

Authors:  S L Binford; F Maldonado; M A Brothers; P T Weady; L S Zalman; J W Meador; D A Matthews; A K Patick
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

6.  Interaction of alphaVbeta3 and alphaVbeta6 integrins with human parechovirus 1.

Authors:  Jani Seitsonen; Petri Susi; Outi Heikkilä; Robert S Sinkovits; Pasi Laurinmäki; Timo Hyypiä; Sarah J Butcher
Journal:  J Virol       Date:  2010-06-16       Impact factor: 5.103

7.  Recombination in circulating enteroviruses.

Authors:  Alexander N Lukashev; Vasilii A Lashkevich; Olga E Ivanova; Galina A Koroleva; Ari E Hinkkanen; Jorma Ilonen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes.

Authors:  M Steven Oberste; Kaija Maher; Mark A Pallansch
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Integrin alpha v beta 6 is an RGD-dependent receptor for coxsackievirus A9.

Authors:  Ciğdem H Williams; Tommi Kajander; Timo Hyypiä; Terry Jackson; Dean Sheppard; Glyn Stanway
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Human parechovirus genotypes -10, -13 and -15 in Pakistani children with acute dehydrating gastroenteritis.

Authors:  Muhammad Masroor Alam; Adnan Khurshid; Shahzad Shaukat; Muhammad Suleman Rana; Salmaan Sharif; Mehar Angez; Nadia Nisar; Muhammad Naeem; Syed Sohail Zahoor Zaidi
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.